HER2+ Metastatic Breast Cancer: Standard of Care Therapies
0 Views
administrator
07/03/23
Sara A. Hurvitz, MD, FACP, provides an overview of the standard of care for the treatment of HER2+ metastatic breast cancer along with treatment with T-DM1 as seen in the EMILIA trial.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
-
Category
Show more
Facebook Comments
No comments found